Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: BJU Int. 2014 Aug 11;114(6):916–925. doi: 10.1111/bju.12778

Table 1. Characteristics of interstitial cystitis/bladder pain syndrome (IC/BPS) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) participants, Washington University School of Medicine and the University of Alabama at Birmingham, 2010-2013.

All (n=76) Female (n=46) Male (n=30) p-value1
Baseline age (years, mean (range)) 47.7 (18.9 -80.0) 46.6 (18.9 - 75.8) 49.4 (26.6 - 80.0) 0.45
Caucasian (%) 88.2 89.1 86.7 0.73
Met IC/BPS criteria at baseline (%)2 94.7 100.0 86.7 0.02
Duration of symptoms at baseline (years, mean (range)) 13.3 (0.2 - 54.2) 16.4 (0.2 - 52.0) 8.6 (0.9 - 54.2) 0.01
Non-flare symptom levels (mean (range)):
 Pelvic pain, pressure, or discomfort in the past two weeks (on a scale of 0-10) 4.2 (0.0 - 10.0) 4.9 (0.0 - 10.0) 3.2 (0.0 - 9.0) 0.007
 Urgency in the past two weeks (on a scale of 0-10) 3.9 (0.0 - 10.0) 4.8 (0.0 - 10.0) 2.6 (0.0 - 8.0) 0.001
 Frequency in the past two weeks (on a scale of 0-10) 4.0 (0.0 - 10.0) 4.9 (0.0 - 10.0) 2.7 (0.0 - 9.0) 0.002
 Genitourinary pain index (on a scale of 0-23) 10.5 (0.0 - 22.0) 11.6 (0.0 - 22.0) 9.0 (0.0 - 20.0) 0.06
 Interstitial cystitis symptom index (on a scale of 0-20) 8.7 (0.0 - 18.0) 10.4 (3.0 - 18.0) 6.4 (0.0 - 16.0) 0.0002
 Interstitial cystitis problem index (on a scale of 0-16) 7.0 (0.0 - 16.0) 8.8 (1.0 - 16.0) 4.8 (0.0 - 14.0) 0.0002
Flare at baseline (%) 33.0 35.6 30.0 0.62
Presence of non-urological associated syndromes (%):3
 Irritable bowel syndrome 26.8 28.6 24.1 0.68
 Fibromyalgia 9.9 14.3 3.5 0.23
 Chronic fatigue syndrome 12.7 19.1 3.5 0.07
 Any associated syndrome 38.0 45.2 27.6 0.13
1

P-values were calculated by Student's t-tests or chi-squared tests, as appropriate.

2

Defined as an unpleasant sensation of pain, pressure, or discomfort perceived to be related to the bladder/prostate and/or pelvic region, associated with lower urinary tract symptoms, for the majority of time in the three months before baseline.

3

Assessed by the Complex Medical Symptoms Inventory[15]